Inhibikase Therapeutics Inc

IKT

Inhibikase Therapeutics Inc has been a target of short sellers for a while. The current short interest of 14.07% is significantly above the average of the last 12 months (10.60%).

Short Interest Trend

Share Price

Total NSP

14.07%

+0.15%

vs. last month

Also interesting? All insider buys at Inhibikase Therapeutics Inc

Found an error? Questions? Ideas?